))
Challenges and Opportunities for South Africa’s New Regulatory System
Archived series ("HTTP Redirect" status)
Replaced by: DIA: Driving Insights to Action
When?
This feed was archived on January 04, 2018 17:42 (
Why? HTTP Redirect status. The feed permanently redirected to another series.
What now? If you were subscribed to this series when it was replaced, you will now be subscribed to the replacement series. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 209890153 series 1875338
Content provided by DIA: Driving Insights to Action. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by DIA: Driving Insights to Action or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
A study published in the July 2018 issue of Therapeutic Innovation & Regulatory Science (TIRS) evaluates the current South African regulatory review process within the MCC, identifying regulatory milestones and review times prior to the establishment of the new South Africa Health Products Regulatory Authority (SAHPRA). Sam Salek, Professor of Pharmacoepidemiology at the School of Life and Medical Sciences, University of Hertfordshire, UK, and co-author of the study discusses the main findings as well as the challenges and opportunities for enhanced regulatory practices in South Africa.
20 episodes
Share
